VRTX
Vertex Pharmaceuticals Incorporated
$378.71
-$4.42(-1.15%)
60
Overall
--
Value
60
Tech
--
Quality
Market Cap
$100.34B
Volume
1.06M
52W Range
$362.50 - $519.88
Target Price
$487.42
EPS Estimates Overview
| Current Quarter | $4.02 | Next Quarter | $4.37 |
| Current Year | $15.88 | Next Year | $17.58 |
| QoQ Growth | +8.7% | YoY Growth | +10.7% |
| 3Y EPS CAGR | -30.6% | Target Price | $487.42 |
| Consensus | Buy | Upside | +28.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $378.71 | -1.2% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW